Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISA 2022 | ISA session highlights: basic research on light chains & cardiotoxicity in amyloidosis

Stefano Ricagno • 6 Sep 2022
ISA 2022
Amyloidosis Rare Diseases

Stefano Ricagno, PhD, University of Milan, Milan, Italy, shares his highlights from the session on basic research on light chains and cardiotoxicity that took place at this year’s ISA meeting, discussing the role of post-translational modifications (PTMs) as a risk factor for AL amyloidosis, and how it is possible to predict amyloidogenic proteins from sequence motifs. This interview took place at the 2022 International Symposium on Amyloidosis (ISA) held in Heidelberg, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Stefano Ricagno

2:51
The role of protein dynamics and proteolysis in light chain amyloid aggregation
Stefano Ricagno • 6 Sep 2022
1:18
What is currently known about AL amyloidosis with cardiac involvement?
Stefano Ricagno • 6 Sep 2022
1:15
An insight into organ dysfunction and damage in AL amyloidosis
Stefano Ricagno • 6 Sep 2022

Related Videos

2:32
Preventative therapeutic phlebotomies for patients with EPP
Rita Beier • 15 Apr 2024
1:07
Key advancements in the treatment of BPDCN from EBMT 2024
Cristina Papayannidis • 22 Apr 2024
1:27
First-line tagraxofusp followed by alloSCT in BPDCN: a case study
Cristina Papayannidis • 22 Apr 2024
2:03
Current SoC for BPDCN and other emerging treatment options
Cristina Papayannidis • 22 Apr 2024
The content of VJHemOnc is intended for healthcare professionals